The effects of cocaine are well documented in the CNS; however, recent
evidence suggests that cocaine may suppress the immune system. Matern
al cocaine use essentially exposes the fetus to a continuous exposure
of cocaine. The objective of this study was to investigate the immunom
odulatory effects of cocaine and its metabolites on maternal and fetal
immune systems. Subjects were recruited from an Investigational Revie
w Board approved protocol, and biologic specimens were collected. For
each subject peripheral blood mononuclear cells (PBMCs) were isolated
by density gradient. Each PBMC sample was stimulated in separate wells
with phytohemagglutinin and phrobol 12-myristate 13-acetate. Samples
were radiolabeled and stimulation was measured. Cytokine measurements
were made on the serum via ELISA assay techniques. In both the phorbol
12-myrisate 13-acetate and the phytohemagglutinin group, the PBMCs is
olated from fetal cord blood in the cocaine-using group had significan
tly (p < 0.05) decreased responses compared with control subjects. IL
1 and LL 2 concentrations were suppressed in the cocaine-exposed fetal
serum compared with controls (p < 0.005 and p < 0.05, respectively).
We have shown that in utero cocaine exposure results in a nonspecific
suppression of fetal T lymphocyte response. The clinical consequences
of prenatal cocaine-induced immunosuppression need to be further explo
red.